Calculation of your study is finished. Please find your results below.

A study for a 82 year old woman who takes Prolia, Atorvastatin Calcium, Potassium, Pentasa, Hydrochlorothiazide, Gabapentin (an AI-powered real world drug study)

Summary:

2 females aged 82 (±5) who take the same drugs and have adverse effects are studied. This is a phase IV clinical study for a 82 year old female patient who has Osteoporosis, High Cholesterol, Potassium - Low, Uc, Water Retention, Nerve Damage - Diabetic. The study is created by eHealthMe based on reports from sources including the FDA.


On Aug, 05, 2026

2 females aged 82 (±5) who take Prolia, Atorvastatin Calcium, Potassium, Pentasa, Hydrochlorothiazide, Gabapentin and have adverse effects are studied.


Number of reports submitted per year:

Prolia, Atorvastatin Calcium, Potassium, Pentasa, Hydrochlorothiazide, Gabapentin for a 82-year old woman.

Information of the patient in this study:

  • Age: 82
  • Gender: female

What are the drugs?

What are the conditions?


Common drug interactions *:

  1. Drug Hypersensitivity : 2 people, 100.00%
  2. Dizziness : 2 people, 100.00%
  3. Spinal Cord Disorder (disease of spinal cord): 1 person, 50.00%
  4. Skin Cancer : 1 person, 50.00%
  5. Pneumonia : 1 person, 50.00%
  6. Oxygen Saturation Decreased : 1 person, 50.00%
  7. Itching : 1 person, 50.00%
  8. Infusion Site Swelling : 1 person, 50.00%
  9. Infusion Site Pain : 1 person, 50.00%
  10. Infusion Site Erythema (reddening of the skin at infusion site): 1 person, 50.00%
  11. Infusion Related Reaction : 1 person, 50.00%
  12. Indigestion : 1 person, 50.00%
  13. Hospitalisation : 1 person, 50.00%
  14. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 50.00%
  15. Asthma : 1 person, 50.00%

Common co-existing conditions *:

You may use this to check any potential undetected conditions.

  1. Sinusitis (inflammation of sinus): 1 person, 50.00%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 50.00%
  3. Immunodeficiency Common Variable : 1 person, 50.00%
  4. Hypersensitivity : 1 person, 50.00%
  5. Diarrhea : 1 person, 50.00%
  6. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 50.00%

Common co-used drugs *:

You may use this to check any potential interacting drugs.

  1. Vitamin D3 (2 people, 100.00%)
  2. Albuterol Sulfate (2 people, 100.00%)
  3. Aspirin (2 people, 100.00%)
  4. Losartan (2 people, 100.00%)
  5. Montelukast Sodium (2 people, 100.00%)
  6. Xyrem (1 person, 50.00%)
  7. Calcium (1 person, 50.00%)
  8. Cobamamide (1 person, 50.00%)
  9. Celebrex (1 person, 50.00%)
  10. Cardizem Cd (1 person, 50.00%)
  11. Baclofen (1 person, 50.00%)
  12. Breo Ellipta (1 person, 50.00%)
  13. Epinephrine (1 person, 50.00%)
  14. Azelastine (1 person, 50.00%)
  15. Alprazolam (1 person, 50.00%)
  16. Albuterol (1 person, 50.00%)
  17. Effexor Xr (1 person, 50.00%)
  18. Imitrex (1 person, 50.00%)
  19. Flonase (1 person, 50.00%)
  20. Xanax (1 person, 50.00%)

Drug effectiveness *:

Prolia:

n/a

Atorvastatin Calcium:

n/a

Potassium:

n/a

Pentasa:

n/a

Hydrochlorothiazide:

n/a

Gabapentin:

n/a

* Some reports may have incomplete information.


How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drug side effects in long term, by gender and age:

Treatments, associated medications and conditions:

Drug interactions:

How the phase IV clinical study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: